Moderna’s virus vaccine costs far more than rival treatments
Moderna, the first pharmaceutical firm to conduct human trials of avaccine in the U.S., is charging as much as $37 per dose for its . That’s more than three times what some industry rivals say they plan to charge for their vaccines.
Individuals are expected to need as many as two doses to fully immunize them from COVID-19, which means treatment could cost as much as $74 per person.
For now, there is no approved vaccine to protect people from the novel coronavirus. But Moderna appears to have a lead on the many drugmakers and biotech firms working to develop one. The Cambridge, Massachusetts-based company of its vaccine in late July, following promising results in an initial test earlier this summer.
Moderna executives expressed confidence that the company’s …continued .
[Source: CBS News]